http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2192905-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fca6426e50f5a2fa20556ab3f33b548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9d72c1e1c4602fdce8d7c413d03de79 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
| filingDate | 1997-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b9dd8ad8815f41015dd027aff0c218e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c9c677a7b8b3a5f67bd9a5cb4b33659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b0e2d3d520708bfc6174cc59514de7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_457e8b2e7205c9f294b944773db8624c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2432184d86b0446c94329f693aad49e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e28681c2b66366652eee1140badb8549 |
| publicationDate | 2002-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2192905-C2 |
| titleOfInvention | Method for treating the cases of posttraumatic cornea dystrophy |
| abstract | FIELD: medicine. SUBSTANCE: method involves performing superficial epithelium layer coagulation by means of CO 2 laser at wavelength of 10.6 mcm, 1 to 10 W power and spot diameter of 300-800 mcm under local anesthesia. Exposure time is 0.1-0.5 s. The number of applications is 4-15. Cornea is then coagulated with infrared laser at 1.54 mcm wavelength, 200 to 800 mJ power and spot diameter of 300-1000 mcm. Exposure time is 1,5•10 -3 s. The number of applications is 5-18. One month later, residual hypermetropic astigmatism correction is carried out by means of cornea coagulation in weak meridian contiguous to dystrophy zone using infrared laser at 1.54 mcm wavelength, 200 to 800 mJ power and spot diameter of 300-1000 mcm. Exposure time is 1,5•10 -3 s. The number of applications is 5-18. EFFECT: enhanced effectiveness of treatment; reduced amblyopia and squint manifestations; improved binocular vision function. |
| priorityDate | 1997-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503036 |
Total number of triples: 20.